Van Andel Institute chief scientist earns $7.9 million Outstanding Investigator Award to support cancer research
2023-09-28
(Press-News.org) GRAND RAPIDS, Mich. (September 28, 2023) — Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has received a seven-year, nearly $7.9 million grant from the National Cancer Institute’s Outstanding Investigator Award program. The funding will fuel his research into the epigenetic errors that drive cancer development — and help him find ways to fix them.
The award is a renewal of an earlier seven-year, $7.8 million Outstanding Investigator Award granted to Jones in 2017. The National Cancer Institute, a part of the National Institutes of Health, launched the Outstanding Investigator Award program in 2014 to support “investigators with outstanding records of cancer research accomplishment by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer.”
“It is an absolute honor to receive a second Outstanding Investigator Award from the National Cancer Institute,” Jones said. “This vital funding will enable us to continue studying the intricate mechanisms that drive cancer — and explore strategies to translate our discoveries into potential new treatments.”
Jones is a globally recognized cancer scientist whose pioneering research in the 1980s helped launch the field of epigenetics, which explores factors that influence gene expression without changing the DNA sequence itself.
Epigenetic errors are present in virtually all human cancers and, for the last 40 years, Jones has been at the forefront of studying how epigenetics influences cancer, work that offers myriad opportunities for breakthrough new treatments. Jones’ research into the epigenetic modifier 5-azacytadine led to its later development and approval for treatment of myelodysplastic syndrome (MDS), a precursor to blood cancer.
The Outstanding Investigator Award will support Jones’ research into a key epigenetic player in cancer: a molecule called DNMT3A, which is involved in brain development, regulation of body size and formation of blood. Errors in DNMT3A are common features of leukemia but little is known about how exactly they drive cancer development.
Jones and his collaborators, which include VAI Assistant Professor Evan Worden, Ph.D., hope to answer key questions about DNMT3A and its role in cancer. To do so, they will leverage VAI’s extensive research infrastructure, including its state-of-the-art cryo-electron microscopy (cryo-EM) suite. Cryo-EM enables scientists to visualize molecules at the near-atomic level, which provides deep insights into how they function in health and disease.
Jones joined VAI as its chief scientific officer in 2013, following 36 years at University of Southern California. Along with longtime collaborator Stephen Baylin, M.D., Jones co-chairs the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team, a multi-institutional effort to evaluate combination therapies for cancer in clinical trials. He is a past president of the American Association for Cancer Research (AAACR), a fellow of the AACR Academy, a fellow of the American Association for the Advancement of Science, a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. Jones and Baylin shared the Kirk A. Landon Award for Basic Cancer Research from AACR in 2009 and the Medal of Honor from the American Cancer Society in 2011.
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award no. R35CA209859 (Jones). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
###
ABOUT VAN ANDEL INSTITUTE
Van Andel Institute (VAI) is committed to improving the health and enhancing the lives of current and future generations through cutting-edge biomedical research and innovative educational offerings. Established in Grand Rapids, Michigan, in 1996 by the Van Andel family, VAI is now home to more than 500 scientists, educators and support staff, who work with a growing number of national and international collaborators to foster discovery. The Institute’s scientists study the origins of cancer, Parkinson’s and other diseases and translate their findings into breakthrough prevention and treatment strategies. Our educators develop inquiry-based approaches for K-12 education to help students and teachers prepare the next generation of problem-solvers, while our Graduate School offers a rigorous, research-intensive Ph.D. program in molecular and cellular biology. Learn more at vai.org.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-09-28
Rockville, MD (September 28, 2023) – The American Society for Nutrition (ASN) announced today that its annual meeting, NUTRITION 2024, will take place in Chicago, Illinois, June 29 - July 2, 2024. NUTRITION 2024 is the premier meeting for the nutrition community, exploring developments in clinical and translational nutrition, food science and systems, diet and disease, basic science, global health, and more. Nutrition scientists are invited to share their research and join together with clinicians, policy experts, industry, and the media to network and learn for 3.5 exciting days in Chicago.
"I look forward to being together with the best in our field. From groundbreaking ...
2023-09-28
Terpenoids, the largest family of natural products, have gained significant attention for their diverse applications in industries such as pharmaceuticals, fragrances, and biofuels. However, the efficient synthesis of terpenoids using engineered cell factories has been hindered by the limited supply of isoprene pyrophosphate (IPP), the key building block for terpenoid production. Now, a research team led by Jian Chen at Jiangnan University in China has made a groundbreaking discovery that could revolutionize terpenoid bioproduction.
In their research article published in the journal Engineering, Chen and his team unveil a novel approach to address the challenge of insufficient IPP ...
2023-09-28
Scientists at The University of Manchester are set to receive a multi-million-pound grant to advance our understanding of interactions in microbiomes and how they might impact the world around us.
The research, funded by the Biotechnology and Biological Sciences Research Council’s (BBSRC) strategic Longer and Larger (sLoLa) grants programme, takes the first major step towards understanding complex microbial communities and will support the move towards a more sustainable and Net Zero ...
2023-09-28
Many of today’s medications belong to groups of relatively large molecules such as peptides. They are used to treat a wide range of diseases, including diabetes, obesity and prostate cancer. Unfortunately, taking these medications in tablet form is out of the question in most cases because they would break down in the digestive tract or remain too large to reach the bloodstream. Consequently, the patient’s only option is to receive their medication via injection.
A group of researchers at ETH Zurich have developed ...
2023-09-28
Scientists have demonstrated the existence of gravity between antimatter and Earth, reaffirming Albert Einstein’s General Theory of Relativity.
It is thought that Isaac Newton's historic work on gravity was inspired by watching an apple fall to Earth from a tree. But for decades, scientists have wondered what would happen to an “anti-apple” made of antimatter - would it fall in the same way if it existed?
Until now, the question has left scientists with an incomplete picture of the Universe's gravitating content.
In a paper published today in Nature, the ALPHA collaboration at CERN’s Antimatter Factory, which ...
2023-09-28
Augmented reality (AR) technology has long fascinated both the scientific community and the general public, remaining a staple of modern science fiction for decades.
In the pursuit of advanced AR assistants – ones that can guide people through intricate surgeries or everyday food preparation, for example – a research team from NYU Tandon School of Engineering has introduced Augmented Reality Guidance and User-Modeling System, or ARGUS.
An interactive visual analytics tool, ARGUS is engineered to support the development of intelligent AR assistants that can run on devices like Microsoft ...
2023-09-28
Normal aging is usually associated with a decline in memory, although it is unclear what factors play a role. In a new study, researchers studied specific interneurons, which serve as communication centers that connect other neurons, in the regions of the brain that are important for learning and memory.
Increasing age places people at risk, whether it is because of a normal decrease in cognitive ability or due to postoperative cognitive disorders. In the latter, the deficits can persist for many months after surgery especially when the patients are older than 60. Unfortunately, the ...
2023-09-28
A new study in JAMA Network Open may provide key answers to how to help people experiencing chronic back pain.
The study, published today, examined the critical connection between the brain and pain for treating chronic pain. Specifically, they looked at the importance of pain attributions, which are people’s beliefs about the underlying causes of their pain, to reduce chronic back pain severity.
“Millions of people are experiencing chronic pain and many haven’t found ways to help with the pain, making it clear that something is missing in the way we’re diagnosing and treating people,” said the ...
2023-09-28
RICHLAND, Wash.—For decades, researchers have assumed that the inevitable filmy buildup on electrodes inside rechargeable batteries is the driver of performance loss. Now, we know that view is backward.
The buildup of mossy or tree-like structured lithium metal deposits on battery electrodes is not the root cause of performance loss, but rather a side effect. The first direct measurement of the electrical properties at the boundary between the solid electrode and the liquid electrolyte inside a rechargeable battery is reported today in Nature Energy.
The study, led by a research team at the Department of Energy’s Pacific Northwest National Laboratory, shows that the so-called ...
2023-09-28
UCLA-led research suggests that diabetes control can significantly improve for Latinos when a pharmacist implements an intervention that addresses these patients’ barriers to medication adherence.
In this pharmacist-led intervention, pharmacists reviewed the patients’ lab results, vital signs, and barriers to adherence. They then used this information to design a personally-tailored intervention to boost medication adherence and optimize the treatment regimen.
The study is the first to evaluate a collaboration between pharmacist and physicians aimed at improving diabetes care in a large healthcare system among Latino patients, said study lead Dr. Kimberly Narain, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Van Andel Institute chief scientist earns $7.9 million Outstanding Investigator Award to support cancer research
